LGC AXIO Proficiency Testing Schemes 2027
Therapeutic Drug Monitoring TDM
“Supporting laboratories’ accuracy and performance, within challenging limits”
Therapeutic Drug Monitoring is a measurement of specific drug concentration levels at timed intervals in patients, usually through blood/serum samples. Such monitoring is necessary where control of drug concentrations is required to achieve optimum treatment for the patient, or where there is a narrow range between the therapeutic and toxic levels. The LGC AXIO Proficiency Testing Therapeutic Drugs Monitoring Scheme (TDM) provides independent performance assessment for the routine quantification of a wide range of anti-epileptic and other therapeutic drugs. The operation of this scheme is supported by an Advisory Group consisting of members of professional bodies, scheme participants, and others experienced in the field. The scheme reports on the performance of UK participants (who have clinical responsibilities) to the National Quality Assurance Advisory Panels for Chemical Pathology.
Types of testing:
Therapeutic Drugs Other Therapeutic Drugs Drugs for Treatment of substance related disorders Anti-Hypertensive Drug Screen
Chemotherapy Drugs Psychoactive Drugs Psychostimulants Smoking Related Drugs Antibiotic and Antifungal Drugs
Download Application Form
Download Scheme Description
The full range and availability of test materials and analytes is determined on an annual basis and may be added or removed. For accredited and non-accredited status, plus the most up to date sample data, please see the current application form/scheme description for this scheme.
114 lgcstandards.com/AXIO-PT
Made with FlippingBook Ebook Creator